Basic Science Seminar - Targetable pathways in liver disease: New targets in inflammation and fibrosis

 General hepatology
 Basic and translational science
 Webcasted session

North 1
English
Basic science seminar
11 April 2018 16:00 - 17:30

The session will turn to candidate targets in progressive liver disease, including those at the inflammatory interface, within the fibrotic milieu, and at the forefront in the treatment of portal hypertension.

Presentations

Modulating danger sensing at the interface to liver inflammation
Wajahat Mehal , United States
11 April 2018 16:00 - 16:10

The role of Pyruvate Kinase M2 in regulating liver inflammation
Wajahat Mehal , United States
11 April 2018 16:10 - 16:20

Modulating danger sensing at the interface to liver inflammation: Discussion
11 April 2018 16:20 - 16:30

Drug targets in the dynamics of liver fibrosis
Neil Henderson , United Kingdom
11 April 2018 16:30 - 16:40

Differential regulation of hepatic fibrosis by mesenchymal subpopulations
Ross Dobie , United Kingdom
11 April 2018 16:40 - 16:50

Drug targets in the dynamics of liver fibrosis: Discussion
11 April 2018 16:50 - 17:00

A molecular perspective to new treatments in portal hypertension
Jordi GRACIA-SANCHO , Spain
11 April 2018 17:00 - 17:10

Liver stiffness: new driver in portal hypertension
Sergi Guixé-Muntet , Switzerland
11 April 2018 17:10 - 17:20

A molecular perspective to new treatments in portal hypertension: Discussion
11 April 2018 17:20 - 17:30